NEW YORK (Reuters Health)—Inflammatory bowel disease (IBD) patients who achieve remission on treatment may want to go off their IBD medications. But half or more of those who do will have a relapse, according to comprehensive analysis of relevant research. “Based on the studies with extended periods of follow up, relapse rates after cessation appear…
IL-26 Plays Antimicrobial Role in Immune Response
Researchers determined IL-26 serves as a potent antimicrobial that promotes the immune sensing of both bacterial and host cell death…
Telehealth Visits May Be an Option After Surgery
(Reuters Health)—People may happily, and safely, forgo in-person doctors’ visits after surgery by opting instead for talking with their surgeons by phone or video, suggests a small study of U.S. veterans. Most patients preferred the virtual visits and the doctors didn’t miss any infections that popped up after surgery, the researchers report in JAMA Surgery….
Moving to ICD-10 Has Promises, Challenges
NEW YORK (Reuters Health)—While the new International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes offer greater diagnostic precision, their implementation will require training of clinicians, coders, and other staff to minimize payment denials or delays from both public and private payers. Brian Outland and colleagues from the American College of Physicians in Washington,…
IBD Tied to Higher Risk of Invasive Pneumococcal Disease
NEW YORK (Reuters Health)—Patients with inflammatory bowel disease (IBD) are at slightly increased risk of invasive pneumococcal disease (IPD), according to Danish researchers. In a paper online Sept. 8 in The American Journal of Gastroenterology, Bjørn Kantsø of Statens Serum Institut in Copenhagen and colleagues note that the inappropriate immune response against infective agents seen in…
ACR’s New AS & Nonradiographic Axial SpA Treatment Recommendations
ATLANTA—The American College of Rheumatology (ACR) has released new recommendations for the treatment of ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (SpA). The guideline was developed with the Spondylitis Association of America (SAA) and the Spondyloarthritis Research and Treatment Network. It summarizes recommendations for both pharmacologic and non-pharmacologic treatments, including rehabilitation, management of patients with…
U.S. Antitrust Lawmakers Express Concern About Insurance Mergers
WASHINGTON (Reuters)—Republican and Democratic lawmakers expressed concern about two multi-billion dollar insurance mergers on Tuesday, using a Senate hearing to take issue with the companies’ arguments that they face expanding competition from new rivals. Sen. Mike Lee (R-UT), who chairs the Senate Judiciary Committee’s antitrust subcommittee, said he was worried that consumers would be “locked…
U.S. Says 17.6 Million Americans Have Gained Health Insurance
(Reuters)—The U.S. national healthcare reform law has extended health insurance coverage to 17.6 million Americans, according to a new government report on Tuesday, up from its previous estimate of 16.4 million. The number of uninsured has decreased because of changes in the law that allowed young people to stay on their parents’ health plans for…
How Medicare’s Chronic Care Management Payments Could Affect Primary Care
(Reuters Health)—Medicare’s new “chronic care management” (CCM) payment program could make it more financially feasible for physicians to deliver services between visits. Under the new program, Medicare could reimburse primary care practices about $40 month for such things as medication management and communication with other doctors for patients who have two or more chronic medical…
FDA Issues Warning for Joint Pain from Diabetes Drugs
Severe and disabling joint pain has been connected to the use of dipeptidyl peptidase-4 inhibitors and combination therapies for diabetes, prompting a new FDA warning…
- « Previous Page
- 1
- …
- 273
- 274
- 275
- 276
- 277
- …
- 308
- Next Page »